LCN2 and acute kidney injury: Currently, only neutrophil gelatinase-associated lipocalin (NGAL), tissue inhibitor of metalloproteinase 2 (TIMP-2), and insulin-like growth factor-binding protein 7 (IGFBP7) are available for clinical determination of subclinical AKI [3,4,5,6].